Global COPD Medicine Market Growth (Status and Outlook) 2023-2029

March 2023 | 104 pages | ID: GB3F1C84A77AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

This is drugs for COPD

LPI (LP Information)' newest research report, the “COPD Medicine Industry Forecast” looks at past sales and reviews total world COPD Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected COPD Medicine sales for 2023 through 2029. With COPD Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COPD Medicine industry.

This Insight Report provides a comprehensive analysis of the global COPD Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COPD Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global COPD Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COPD Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COPD Medicine.

The global COPD Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for COPD Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for COPD Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for COPD Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key COPD Medicine players cover GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi and Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of COPD Medicine market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Inhalable & Nasal Spray
• Oral
• Others

Segmentation by application

• Hospital
• Drugs Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GSK
• AstraZeneca
• Boehringer Ingelheim
• Vertex
• Roche
• Novartis
• Teva
• Chiesi
• Mylan
• Sumitomo Dainippon
• Merck
• Beximco

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global COPD Medicine Market Size 2018-2029
  2.1.2 COPD Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 COPD Medicine Segment by Type
  2.2.1 Inhalable & Nasal Spray
  2.2.2 Oral
  2.2.3 Others
2.3 COPD Medicine Market Size by Type
  2.3.1 COPD Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global COPD Medicine Market Size Market Share by Type (2018-2023)
2.4 COPD Medicine Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
2.5 COPD Medicine Market Size by Application
  2.5.1 COPD Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global COPD Medicine Market Size Market Share by Application (2018-2023)

3 COPD MEDICINE MARKET SIZE BY PLAYER

3.1 COPD Medicine Market Size Market Share by Players
  3.1.1 Global COPD Medicine Revenue by Players (2018-2023)
  3.1.2 Global COPD Medicine Revenue Market Share by Players (2018-2023)
3.2 Global COPD Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 COPD MEDICINE BY REGIONS

4.1 COPD Medicine Market Size by Regions (2018-2023)
4.2 Americas COPD Medicine Market Size Growth (2018-2023)
4.3 APAC COPD Medicine Market Size Growth (2018-2023)
4.4 Europe COPD Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa COPD Medicine Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas COPD Medicine Market Size by Country (2018-2023)
5.2 Americas COPD Medicine Market Size by Type (2018-2023)
5.3 Americas COPD Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC COPD Medicine Market Size by Region (2018-2023)
6.2 APAC COPD Medicine Market Size by Type (2018-2023)
6.3 APAC COPD Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe COPD Medicine by Country (2018-2023)
7.2 Europe COPD Medicine Market Size by Type (2018-2023)
7.3 Europe COPD Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa COPD Medicine by Region (2018-2023)
8.2 Middle East & Africa COPD Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa COPD Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL COPD MEDICINE MARKET FORECAST

10.1 Global COPD Medicine Forecast by Regions (2024-2029)
  10.1.1 Global COPD Medicine Forecast by Regions (2024-2029)
  10.1.2 Americas COPD Medicine Forecast
  10.1.3 APAC COPD Medicine Forecast
  10.1.4 Europe COPD Medicine Forecast
  10.1.5 Middle East & Africa COPD Medicine Forecast
10.2 Americas COPD Medicine Forecast by Country (2024-2029)
  10.2.1 United States COPD Medicine Market Forecast
  10.2.2 Canada COPD Medicine Market Forecast
  10.2.3 Mexico COPD Medicine Market Forecast
  10.2.4 Brazil COPD Medicine Market Forecast
10.3 APAC COPD Medicine Forecast by Region (2024-2029)
  10.3.1 China COPD Medicine Market Forecast
  10.3.2 Japan COPD Medicine Market Forecast
  10.3.3 Korea COPD Medicine Market Forecast
  10.3.4 Southeast Asia COPD Medicine Market Forecast
  10.3.5 India COPD Medicine Market Forecast
  10.3.6 Australia COPD Medicine Market Forecast
10.4 Europe COPD Medicine Forecast by Country (2024-2029)
  10.4.1 Germany COPD Medicine Market Forecast
  10.4.2 France COPD Medicine Market Forecast
  10.4.3 UK COPD Medicine Market Forecast
  10.4.4 Italy COPD Medicine Market Forecast
  10.4.5 Russia COPD Medicine Market Forecast
10.5 Middle East & Africa COPD Medicine Forecast by Region (2024-2029)
  10.5.1 Egypt COPD Medicine Market Forecast
  10.5.2 South Africa COPD Medicine Market Forecast
  10.5.3 Israel COPD Medicine Market Forecast
  10.5.4 Turkey COPD Medicine Market Forecast
  10.5.5 GCC Countries COPD Medicine Market Forecast
10.6 Global COPD Medicine Forecast by Type (2024-2029)
10.7 Global COPD Medicine Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 GSK
  11.1.1 GSK Company Information
  11.1.2 GSK COPD Medicine Product Offered
  11.1.3 GSK COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 GSK Main Business Overview
  11.1.5 GSK Latest Developments
11.2 AstraZeneca
  11.2.1 AstraZeneca Company Information
  11.2.2 AstraZeneca COPD Medicine Product Offered
  11.2.3 AstraZeneca COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 AstraZeneca Main Business Overview
  11.2.5 AstraZeneca Latest Developments
11.3 Boehringer Ingelheim
  11.3.1 Boehringer Ingelheim Company Information
  11.3.2 Boehringer Ingelheim COPD Medicine Product Offered
  11.3.3 Boehringer Ingelheim COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Boehringer Ingelheim Main Business Overview
  11.3.5 Boehringer Ingelheim Latest Developments
11.4 Vertex
  11.4.1 Vertex Company Information
  11.4.2 Vertex COPD Medicine Product Offered
  11.4.3 Vertex COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Vertex Main Business Overview
  11.4.5 Vertex Latest Developments
11.5 Roche
  11.5.1 Roche Company Information
  11.5.2 Roche COPD Medicine Product Offered
  11.5.3 Roche COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Roche Main Business Overview
  11.5.5 Roche Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis COPD Medicine Product Offered
  11.6.3 Novartis COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 Teva
  11.7.1 Teva Company Information
  11.7.2 Teva COPD Medicine Product Offered
  11.7.3 Teva COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Teva Main Business Overview
  11.7.5 Teva Latest Developments
11.8 Chiesi
  11.8.1 Chiesi Company Information
  11.8.2 Chiesi COPD Medicine Product Offered
  11.8.3 Chiesi COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Chiesi Main Business Overview
  11.8.5 Chiesi Latest Developments
11.9 Mylan
  11.9.1 Mylan Company Information
  11.9.2 Mylan COPD Medicine Product Offered
  11.9.3 Mylan COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Mylan Main Business Overview
  11.9.5 Mylan Latest Developments
11.10 Sumitomo Dainippon
  11.10.1 Sumitomo Dainippon Company Information
  11.10.2 Sumitomo Dainippon COPD Medicine Product Offered
  11.10.3 Sumitomo Dainippon COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Sumitomo Dainippon Main Business Overview
  11.10.5 Sumitomo Dainippon Latest Developments
11.11 Merck
  11.11.1 Merck Company Information
  11.11.2 Merck COPD Medicine Product Offered
  11.11.3 Merck COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Merck Main Business Overview
  11.11.5 Merck Latest Developments
11.12 Beximco
  11.12.1 Beximco Company Information
  11.12.2 Beximco COPD Medicine Product Offered
  11.12.3 Beximco COPD Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Beximco Main Business Overview
  11.12.5 Beximco Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. COPD Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Inhalable & Nasal Spray
Table 3. Major Players of Oral
Table 4. Major Players of Others
Table 5. COPD Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global COPD Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global COPD Medicine Market Size Market Share by Type (2018-2023)
Table 8. COPD Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global COPD Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global COPD Medicine Market Size Market Share by Application (2018-2023)
Table 11. Global COPD Medicine Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global COPD Medicine Revenue Market Share by Player (2018-2023)
Table 13. COPD Medicine Key Players Head office and Products Offered
Table 14. COPD Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global COPD Medicine Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global COPD Medicine Market Size Market Share by Regions (2018-2023)
Table 19. Global COPD Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global COPD Medicine Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas COPD Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas COPD Medicine Market Size Market Share by Country (2018-2023)
Table 23. Americas COPD Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas COPD Medicine Market Size Market Share by Type (2018-2023)
Table 25. Americas COPD Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas COPD Medicine Market Size Market Share by Application (2018-2023)
Table 27. APAC COPD Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC COPD Medicine Market Size Market Share by Region (2018-2023)
Table 29. APAC COPD Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC COPD Medicine Market Size Market Share by Type (2018-2023)
Table 31. APAC COPD Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC COPD Medicine Market Size Market Share by Application (2018-2023)
Table 33. Europe COPD Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe COPD Medicine Market Size Market Share by Country (2018-2023)
Table 35. Europe COPD Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe COPD Medicine Market Size Market Share by Type (2018-2023)
Table 37. Europe COPD Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe COPD Medicine Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa COPD Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa COPD Medicine Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa COPD Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa COPD Medicine Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa COPD Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa COPD Medicine Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of COPD Medicine
Table 46. Key Market Challenges & Risks of COPD Medicine
Table 47. Key Industry Trends of COPD Medicine
Table 48. Global COPD Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global COPD Medicine Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global COPD Medicine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global COPD Medicine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. GSK Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 53. GSK COPD Medicine Product Offered
Table 54. GSK COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. GSK Main Business
Table 56. GSK Latest Developments
Table 57. AstraZeneca Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 58. AstraZeneca COPD Medicine Product Offered
Table 59. AstraZeneca Main Business
Table 60. AstraZeneca COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. AstraZeneca Latest Developments
Table 62. Boehringer Ingelheim Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 63. Boehringer Ingelheim COPD Medicine Product Offered
Table 64. Boehringer Ingelheim Main Business
Table 65. Boehringer Ingelheim COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Boehringer Ingelheim Latest Developments
Table 67. Vertex Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 68. Vertex COPD Medicine Product Offered
Table 69. Vertex Main Business
Table 70. Vertex COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Vertex Latest Developments
Table 72. Roche Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 73. Roche COPD Medicine Product Offered
Table 74. Roche Main Business
Table 75. Roche COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Roche Latest Developments
Table 77. Novartis Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 78. Novartis COPD Medicine Product Offered
Table 79. Novartis Main Business
Table 80. Novartis COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Novartis Latest Developments
Table 82. Teva Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 83. Teva COPD Medicine Product Offered
Table 84. Teva Main Business
Table 85. Teva COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Teva Latest Developments
Table 87. Chiesi Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 88. Chiesi COPD Medicine Product Offered
Table 89. Chiesi Main Business
Table 90. Chiesi COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Chiesi Latest Developments
Table 92. Mylan Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 93. Mylan COPD Medicine Product Offered
Table 94. Mylan Main Business
Table 95. Mylan COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Mylan Latest Developments
Table 97. Sumitomo Dainippon Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 98. Sumitomo Dainippon COPD Medicine Product Offered
Table 99. Sumitomo Dainippon Main Business
Table 100. Sumitomo Dainippon COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Sumitomo Dainippon Latest Developments
Table 102. Merck Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 103. Merck COPD Medicine Product Offered
Table 104. Merck COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Beximco Details, Company Type, COPD Medicine Area Served and Its Competitors
Table 108. Beximco COPD Medicine Product Offered
Table 109. Beximco Main Business
Table 110. Beximco COPD Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Beximco Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. COPD Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global COPD Medicine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. COPD Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. COPD Medicine Sales Market Share by Country/Region (2022)
Figure 8. COPD Medicine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global COPD Medicine Market Size Market Share by Type in 2022
Figure 10. COPD Medicine in Hospital
Figure 11. Global COPD Medicine Market: Hospital (2018-2023) & ($ Millions)
Figure 12. COPD Medicine in Drugs Store
Figure 13. Global COPD Medicine Market: Drugs Store (2018-2023) & ($ Millions)
Figure 14. Global COPD Medicine Market Size Market Share by Application in 2022
Figure 15. Global COPD Medicine Revenue Market Share by Player in 2022
Figure 16. Global COPD Medicine Market Size Market Share by Regions (2018-2023)
Figure 17. Americas COPD Medicine Market Size 2018-2023 ($ Millions)
Figure 18. APAC COPD Medicine Market Size 2018-2023 ($ Millions)
Figure 19. Europe COPD Medicine Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa COPD Medicine Market Size 2018-2023 ($ Millions)
Figure 21. Americas COPD Medicine Value Market Share by Country in 2022
Figure 22. United States COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC COPD Medicine Market Size Market Share by Region in 2022
Figure 27. APAC COPD Medicine Market Size Market Share by Type in 2022
Figure 28. APAC COPD Medicine Market Size Market Share by Application in 2022
Figure 29. China COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 33. India COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe COPD Medicine Market Size Market Share by Country in 2022
Figure 36. Europe COPD Medicine Market Size Market Share by Type (2018-2023)
Figure 37. Europe COPD Medicine Market Size Market Share by Application (2018-2023)
Figure 38. Germany COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 39. France COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa COPD Medicine Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa COPD Medicine Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa COPD Medicine Market Size Market Share by Application (2018-2023)
Figure 46. Egypt COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country COPD Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 52. APAC COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 53. Europe COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 55. United States COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 56. Canada COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 57. Mexico COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 58. Brazil COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 59. China COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 60. Japan COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 61. Korea COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 63. India COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 64. Australia COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 65. Germany COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 66. France COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 67. UK COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 68. Italy COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 69. Russia COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 70. Spain COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 71. Egypt COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 72. South Africa COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 73. Israel COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 74. Turkey COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries COPD Medicine Market Size 2024-2029 ($ Millions)
Figure 76. Global COPD Medicine Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global COPD Medicine Market Size Market Share Forecast by Application (2024-2029)